Paul Bisaro

Affiliations

  • Director at Myriad Genetics Inc (MYGN), 2025-06-06
  • Director at Zoetis Inc. (ZTS), 2025-02-20
  • Director at Mallinckrodt Plc (NONE), 2025-01-02
  • Director at Therapeuticsmd Inc. (TXMD), 2022-10-03
  • Executive Chairman at Amneal Pharmaceuticals Inc. (AMRX), 2019-05-09
  • President And Ceo at Impax Laboratories Llc (IPXL), 2018-05-08
  • Director at Allergan Plc (AGN), 2018-05-04
  • Director at Zimmer Biomet Holdings Inc. (ZBH), 2017-04-04
  • President & Ceo at Actavis Inc. (ACT), 2013-10-03
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MNK $8.47 5,000 $42,329.50 74,820 2023-03-14 Filing
TXMD $0.79 50,000 $39,500.00 196,864 2021-08-16 Filing
TXMD $1.14 50,000 $57,000.00 50,000 2020-06-04 Filing
AMRX $11.97 17,000 $203,490.00 17,000 2019-03-12 Filing
AGN $297.42 1,000 $297,421.50 421,755 2015-08-24 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AGN $248.40 2,371 $588,956.40 235,900 2017-03-02 Filing
AGN $247.63 27,688 $6,856,379.44 238,271 2017-03-02 Filing
AGN $246.64 8,267 $2,038,972.88 265,959 2017-03-02 Filing
AGN $245.73 31,674 $7,783,252.02 274,226 2017-03-02 Filing
ACT $159.07 17,643 $2,806,472.01 399,995 2013-11-11 Filing